**Core Concept**
The underlying principle being tested is the neurochemical basis of schizophrenia, focusing on the neurotransmitter most commonly implicated in its aetiology. **Dopamine** is a key player in the pathophysiology of psychiatric disorders. Neurotransmitter imbalance, particularly dopamine, is crucial in understanding schizophrenia.

**Why the Correct Answer is Right**
The correct answer is related to the **dopamine hypothesis** of schizophrenia, which suggests that an overactive dopaminergic signal transduction or abnormality in the dopamine receptor density is a factor in the development of schizophrenia. This hypothesis is supported by the efficacy of **dopamine receptor antagonists** (typical antipsychotics) in treating the disease.

**Why Each Wrong Option is Incorrect**
**Option A:** Is incorrect because while other neurotransmitters like serotonin are involved in psychiatric diseases, they are not the most commonly implicated in schizophrenia.
**Option B:** and **Option C:** Are also incorrect as they do not directly relate to the primary neurotransmitter implicated in the aetiology of schizophrenia.

**Clinical Pearl / High-Yield Fact**
A key point to remember is the **dopamine hypothesis**, which links dopamine dysfunction to the symptoms of schizophrenia. This is crucial for understanding the pharmacological management of the disease.

**Correct Answer:** D. Dopamine